Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 5Terminated 3Recruiting 2Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 77NIH 5UNKNOWN 3OTHER_GOV 3NETWORK 3INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 1

Interventions

Injections 53Cisplatin 47Paclitaxel 46Carboplatin 41Gemcitabine 37Docetaxel 36Capecitabine 36pembrolizumab 35Drug Therapy 34anlotinib 25icotinib 23Fluorouracil 23Bevacizumab 23Cyclophosphamide 22Oxaliplatin 19fludarabine 18Pemetrexed 17Irinotecan 16Leucovorin 15Temozolomide 14Doxorubicin 14Cetuximab 14camrelizumab 13apatinib 13Nivolumab 13Trastuzumab 11Rituximab 11Etoposide 11tesetaxel 10SHR-1701 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Radiotherapy, Intensity-Modulated × Clear all
NCT06011291 2023-10-27

A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
73 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡